4521 科研製薬

4521
2024/11/08
時価
1777億円
PER 予
10.32倍
2010年以降
7.89-28.14倍
(2010-2024年)
PBR
0.95倍
2010年以降
0.83-5.86倍
(2010-2024年)
配当 予
4.91%
ROE 予
9.2%
ROA 予
7.59%
資料
Link
CSV,JSON

四半期純利益、少数株主損益調整前当年度純利益

【期間】
年度四半期純利益少数株主損益調整前当年度純利益
2010/0624.2億24.2億
2010/0942.4億 +75%42.4億 +75%
2010/1270.1億 +65.2%70.1億 +65.2%
2011/0382.1億 +17.2%82.1億 +17.2%
2011/0621.8億 -73.5%21.8億 -73.5%
2011/0946.1億 +111.3%46.1億 +111.3%
2011/1266.6億 +44.5%66.6億 +44.5%
2012/0382.8億 +24.4%82.8億 +24.4%
2012/0621億 -74.6%21億 -74.6%
2012/0946.2億 +119.6%46.2億 +119.6%
2012/1273.8億 +59.9%73.8億 +59.9%
2013/0389.9億 +21.8%89.9億 +21.8%
2013/0622.1億 -75.5%22.1億 -75.5%
2013/0946億 +108.3%46億 +108.3%
2013/1274.3億 +61.6%74.3億 +61.6%
2014/0397.4億 +31%97.4億 +31%
2014/0626.3億 -73%26.3億 -73%
2014/0956.4億 +114.4%56.4億 +114.4%
2014/1296.1億 +70.3%96.1億 +70.3%
2015/03121億 +26.2%121億 +26.2%
2015/0663億 -48%63億 -48%
2015/09125億 +98.1%125億 +98.1%
2015/12201億 +61.3%201億 +61.3%
2016/03211億 +5%211億 +5%
2016/0658億 -72.6%58億 -72.6%
2016/09114億 +97.5%114億 +97.5%
2016/12180億 +57.1%180億 +57.1%
2017/03220億 +22.4%220億 +22.4%
2017/0654.6億 -75.2%54.6億 -75.2%
2017/09109億 +98.9%109億 +98.9%
2017/12169億 +55.1%169億 +55.1%
2018/03190億 +13%190億 +13%
2018/0640.4億 -78.8%40.4億 -78.8%
2018/0988.4億 +119.1%88.4億 +119.1%
2018/12142億 +61.2%142億 +61.2%
2019/03178億 +24.8%178億 +24.8%
2019/0648.3億 -72.8%48.3億 -72.8%
2019/0995.5億 +97.8%95.5億 +97.8%
2019/12156億 +62.9%156億 +62.9%
2020/03194億 +24.5%194億 +24.5%
2020/0638.2億 -80.3%38.2億 -80.3%
2020/0972.3億 +89.2%72.3億 +89.2%
2020/12109億 +51.3%109億 +51.3%
2021/03134億 +22.6%134億 +22.6%
2021/0633.6億 -74.9%33.6億 -74.9%
2021/0967.2億 +99.9%67.2億 +99.9%
2021/12102億 +52.4%102億 +52.4%
2022/0395.5億 -6.8%95.5億 -6.8%
2022/0629.1億 -69.6%29.1億 -69.6%
2022/0959.6億 +105.2%59.6億 +105.2%
2022/1291.5億 +53.4%91.5億 +53.4%
2023/0354.4億 -40.5%54.4億 -40.5%
2023/0625.1億 -53.9%25.1億 -53.9%
2023/0940.7億 +62.1%40.7億 +62.1%
2023/1266.8億 +64.1%66.8億 +64.1%
2024/0380.3億 +20.2%80.3億 +20.2%
2024/0617.5億 -78.1%17.5億 -78.1%
2024/09143億 +714.5%143億 +714.5%